Compounds > bezafibrate
Page last updated: 2024-08-23

bezafibrate and Enlarged Liver

bezafibrate has been researched along with Enlarged Liver in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Suomalainen, A; Yatsuga, S1
Dillon, LM; Garcia, S; Hida, A; Moraes, CT; Prolla, TA1
Lazarow, PB; Leroy-Houyet, MA; Shio, H1
Berlot, JP; Cherkaoui Malki, M; Jannin, B; Latruffe, N; Lutz, T; Nicolas-Frances, V1
Bonner, FW; Gibson, GG; Makowska, JM1

Other Studies

5 other study(ies) available for bezafibrate and Enlarged Liver

ArticleYear
Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice.
    Human molecular genetics, 2012, Feb-01, Volume: 21, Issue:3

    Topics: Adipose Tissue; Animals; Bezafibrate; Body Temperature; Disease Progression; DNA Helicases; DNA, Mitochondrial; Electron Transport Complex IV; Female; Fibroblast Growth Factors; Hepatomegaly; Lipid Metabolism; Liver; Male; Mice; Mitochondria; Mitochondrial Myopathies; Mitochondrial Proteins; Muscle Fibers, Skeletal; Mutation; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Peroxisome Proliferator-Activated Receptors; RNA, Messenger; Trans-Activators; Transcription Factors; Weight Loss

2012
Long-term bezafibrate treatment improves skin and spleen phenotypes of the mtDNA mutator mouse.
    PloS one, 2012, Volume: 7, Issue:9

    Topics: Aging, Premature; Animals; Bezafibrate; DNA, Mitochondrial; Energy Metabolism; Fatty Acids; Hepatomegaly; Humans; Hypolipidemic Agents; Male; Mice; Mice, Transgenic; Mitochondria; Mutation; Oxidation-Reduction; Phenotype; PPAR gamma; Skin; Species Specificity; Spleen

2012
Specificity in the action of hypolipidemic drugs: increase of peroxisomal beta-oxidation largely dissociated from hepatomegaly and peroxisome proliferation in the rat.
    Journal of lipid research, 1982, Volume: 23, Issue:2

    Topics: Animals; Bezafibrate; Cell Division; Cell Fractionation; Clofibrate; Clofibric Acid; Female; Hepatomegaly; Hypolipidemic Agents; Male; Microbodies; Organ Size; Organoids; Rats; Rats, Inbred F344; Sex Factors

1982
Properties of a fluorescent bezafibrate derivative (DNS-X). A new tool to study peroxisome proliferation and fatty acid beta-oxidation.
    Lipids, 2000, Volume: 35, Issue:12

    Topics: Animals; Bezafibrate; Cell Division; Cells, Cultured; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Cytosol; Fatty Acids; Fluorescent Dyes; Hepatomegaly; Kinetics; Liver; Magnetic Resonance Spectroscopy; Male; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Models, Chemical; Oxidoreductases; Oxygen; Peroxisome Proliferators; Peroxisomes; Plasmids; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Time Factors; Titrimetry; Transcription Factors; Transfection; Tumor Cells, Cultured

2000
Hepatic induction potency of hypolipidaemic drugs in the rat following long-term administration: influence of different dosing regimens.
    Xenobiotica; the fate of foreign compounds in biological systems, 1990, Volume: 20, Issue:11

    Topics: Animals; Bezafibrate; Clofibric Acid; Fibric Acids; Glutathione Peroxidase; Hepatomegaly; Hypolipidemic Agents; Liver; Male; Microbodies; Rats

1990